Patients' and caregivers' experiences of driving with chronic breathlessness before and after regular low-dose sustained-release morphine: A qualitative study

被引:3
|
作者
Ferreira, Diana H. [1 ]
Boland, Jason W. [2 ]
Kochovska, Slavica [3 ]
Honson, Aaron [1 ]
Phillips, Jane L. [3 ]
Currow, David C. [1 ,2 ,3 ]
机构
[1] Flinders Univ S Australia, Palliat & Support Serv, Flinders Dr, Bedford Pk, SA 5042, Australia
[2] Univ Hull, Wolfson Palliat Care Res Ctr, Hull York Med Sch, Kingston Upon Hull, N Humberside, England
[3] Univ Technol Sydney, Fac Hlth, IMPACCT, Ultimo, NSW, Australia
关键词
Driving; opioids; morphine; breathlessness; dyspnoea; caregivers; patients; REFRACTORY DYSPNEA; OPIOIDS; CARE; CESSATION; HEALTH; COMMUNICATION; PERFORMANCE; PREVALENCE; ATTITUDES; PEOPLE;
D O I
10.1177/0269216320929549
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Chronic breathlessness is a disabling syndrome that profoundly impacts patients' and caregivers' lives. Driving is important for most people, including those with advanced disease. Regular, low-dose, sustained-release morphine safely reduces breathlessness, but little is known about its impact on driving. Aim: To understand patients' and caregivers' (1) perspectives and experiences of driving with chronic breathlessness; and (2) perceived impact of regular, low-dose, sustained-release morphine on driving. Design: A qualitative study embedded in a pragmatic, phase III, randomised, placebo-controlled trial of low-dose, sustained-release morphine (<= 32 mg/24 h) for chronic breathlessness. Semi-structured interviews were conducted immediately after participants withdrew or completed the randomised, placebo-controlled trial. Informed by grounded theory, a constant comparative approach to analysis was adopted. Setting/participants: Participants were recruited from an outpatients palliative care service in Adelaide, Australia. Participants included patients (n = 13) with severe breathlessness associated with chronic obstructive pulmonary disease and their caregivers (n = 9). Results: Participants were interviewed at home. Eleven received morphine 8-32 mg. Three themes emerged: (1) independence; (2) breathlessness' impact on driving; and (3) driving while taking regular, low-dose, sustained-release morphine. Conclusion: Driving contributed to a sense of identity and independence. Being able to drive increased the physical and social space available to patients and caregivers, their social engagement and well-being. Patients reported breathlessness at rest may impair driving skills, while the introduction of sustained-release morphine seemed to have no self-reported impact on driving. Investigating this last perception objectively, especially in terms of safety, is the subject of ongoing work.
引用
下载
收藏
页码:1078 / 1087
页数:10
相关论文
共 29 条
  • [21] Analysis of the Expression of anti-oxidative Factors in the Blood of Patients with chronic degenerative and inflammatory Diseases before and after Low-dose Irradiation - IMMO-LDRT01 Study
    Hehlgans, S.
    Donaubauer, A. -J.
    Becker, I.
    Frey, B.
    Ott, O. J.
    Weissmann, T.
    Fournier, C.
    Gaipl, U. S.
    Roedel, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S143 - S144
  • [22] Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy-tolerability pilot study
    Petro, Emiliano
    Ruffini, Elena
    Cappuccio, Melania
    Guerini, Valeria
    Belotti, Gloria
    Fascendini, Sara
    Licini, Cristina
    Marcassa, Claudio
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 559 - 569
  • [23] Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study
    Cayssials, Emilie
    Torregrosa-Diaz, Jose
    Gallego-Hernanz, Pilar
    Tartarin, Florence
    Systchenko, Thomas
    Maillard, Natacha
    Desmier, Deborah
    Machet, Antoine
    Fleck, Emmanuel
    Corby, Anne
    Motard, Carine
    Denis, Guillaume
    Herbelin, Andre
    Gombert, Jean-Marc
    Roy, Lydia
    Ragot, Stephanie
    Leleu, Xavier
    Guilhot, Francois
    Chomel, Jean-Claude
    CANCER, 2020, 126 (15) : 3438 - 3447
  • [24] Therapeutic Alliance: Patients' Expectations Before and Experiences After Physical Therapy for Low Back Pain-A Qualitative Study With 6-Month Follow-Up
    Unsgaard-Tondel, Monica
    Soderstrom, Sylvia
    PHYSICAL THERAPY, 2021, 101 (11):
  • [25] Patients' expectations of physiotherapists before and after an intensive chronic low back pain rehabilitation programme: a qualitative study based on semi-structured interviews and observations
    Pichonnaz, Claude
    Ancey, Celine
    Mbarga, Josiane
    Foley, Rose-Anna
    DISABILITY AND REHABILITATION, 2024, 46 (09) : 1776 - 1786
  • [26] Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study
    Campiotti, Leonardo
    Suter, Matteo B.
    Dentali, Francesco
    CANCER, 2021, 127 (06) : 978 - 978
  • [27] Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study
    Cayssials, Emilie
    Torregrosa-Diaz, Jose
    Leleu, Xavier
    Guilhot, Francois
    Chomel, Jean-Claude
    CANCER, 2021, 127 (06) : 976 - 978
  • [28] Efficacy of low-dose and long-term administration of IFN-alpha 2a in patients with chronic hepatitis C who failed to obtain sustained viral response by after PEG-IFN plus ribavirin therapy
    Kogame, Michio
    Shinohara, Mie
    Ishii, Koji
    Shinohara, Masao
    Ikehara, Takashi
    Nagai, Hidenari
    Watanabe, Manabu
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 192 - 192
  • [29] Efficacy and Safety of Low-Dose Transdermal Buprenorphine Patches (5, 10, and 20 μg/h) Versus Prolonged-Release Tramadol Tablets (75, 100, 150, and 200 mg) in Patients With Chronic Osteoarthritis Pain: A 12-Week, Randomized, Open-Label, Controlled, Parallel-Group Noninferiority Study
    Karlsson, Mats
    Berggren, Anna-Carin
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 503 - 513